David Collier
Vorstandsvorsitzender bei Velocity Pharmaceutical Development LLC
Profil
David J.
Collier is the founder of Velocity Pharmaceutical Development LLC, founded in 2011, where he holds the title of Chief Executive Officer.
He is also the founder of Velocity Pharmaceutical Holdings LLC and X-37 Service Co., Inc. Dr. Collier's current job(s) include being the Chairman at Arcion Therapeutics LLC since 2013 and a Director at Reeve Foundation - Presidio Partners NRT LP.
Dr. Collier's former job(s) include being the Chief Executive Officer at England & Wales Cricket Board Ltd., Corsair Pharma, Inc., and Burrill LLC.
He also served as a Director at Sorbent Therapeutics, Inc., SurgiQuest, Inc., Menlo Therapeutics, Inc., Arcadia Biosciences, Inc., Predix Pharmaceuticals Holdings, Inc., VeraLight, Inc., Auspex Pharmaceuticals, Inc., Ardelyx, Inc., Exela Pharma Sciences LLC, Vallinex, Inc., Arthur D.
Little, Inc., and First Options of Chicago, Inc.Dr. Collier's education history includes an undergraduate degree from Wesleyan University, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Perelman School of Medicine.
Aktive Positionen von David Collier
Unternehmen | Position | Beginn |
---|---|---|
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Vorsitzender | 21.12.2013 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Vorstandsvorsitzender | 01.01.2011 |
Reeve Foundation - Presidio Partners NRT LP
Reeve Foundation - Presidio Partners NRT LP Investment ManagersFinance Reeve Foundation - Presidio Partners NRT LP is a special purpose vehicle formed to invest in NeuroRecovery Technologies Inc. | Direktor/Vorstandsmitglied | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | Gründer | - |
Ehemalige bekannte Positionen von David Collier
Unternehmen | Position | Ende |
---|---|---|
Presidio Partners
Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.05.2020 |
England & Wales Cricket Board Ltd.
England & Wales Cricket Board Ltd. Movies/EntertainmentConsumer Services England & Wales Cricket Board Ltd. operates professional sports teams and organizations. The company also operates various charities such as cricket foundation, and programs like building partnerships. England & Wales Cricket Board was founded in 1997 and is headquartered in London, UK. | Vorstandsvorsitzender | 31.07.2014 |
ARDELYX, INC. | Direktor/Vorstandsmitglied | 01.03.2014 |
AUSPEX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 07.01.2014 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Direktor/Vorstandsmitglied | 01.01.2014 |
Ausbildung von David Collier
Wesleyan University | Undergraduate Degree |
Perelman School of Medicine | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ARDELYX, INC. | Health Technology |
ARCADIA BIOSCIENCES, INC. | Process Industries |
Private Unternehmen | 19 |
---|---|
Presidio Partners
Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Finance |
Exela Pharma Sciences LLC
Exela Pharma Sciences LLC Pharmaceuticals: MajorHealth Technology Exela Pharma Sciences LLC develops and manufactures generic injectable, ophthalmic and inhalation pharmaceutical products. It offers analytical, formulation, lyophilization cycle development, and manufacturing and microbiology services and also operates a sterile manufacturing facility. The firm transforms product development ideas into clinically safe and effective medicines. It works to bring to the market a number of pharmaceutical products covering multiple therapeutic areas and dosage forms. Exela Pharma Sciences was founded by S.R. Murthy Mallipeddi and Phanesh Koneru in 2005 and is headquartered in Lenoir, NC. | Health Technology |
Predix Pharmaceuticals Holdings, Inc.
Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals Holdings, Inc. is a pharmaceutical company focused on the discovery and development of novel, highly selective, small-molecule drugs that target G-Protein Coupled Receptors (GPCRs) and ion channels. | Health Technology |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Health Technology |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Retail Trade |
England & Wales Cricket Board Ltd.
England & Wales Cricket Board Ltd. Movies/EntertainmentConsumer Services England & Wales Cricket Board Ltd. operates professional sports teams and organizations. The company also operates various charities such as cricket foundation, and programs like building partnerships. England & Wales Cricket Board was founded in 1997 and is headquartered in London, UK. | Consumer Services |
Vallinex, Inc.
Vallinex, Inc. Pharmaceuticals: MajorHealth Technology Vallinex, Inc. provides chronic pain relief products. Its product, VLNX-4975 is used to treat the osteoarthritis and other chronic pain conditions. The company is headquartered in Baltimore, MD. | Health Technology |
VeraLight, Inc.
VeraLight, Inc. Medical SpecialtiesHealth Technology VeraLight, Inc. develops noninvasive technologies for the disease detection and health monitoring of diabetes epidemics. It offers a noninvasive diabetes screening system designed to provide a method for screening pre-diabetes based on the presence of diabetes-related biomarkers found in skin. The company was founded by David Van Avermaete and John Maynard in October 2004 and is headquartered in Albuquerque, NM. | Health Technology |
First Options of Chicago, Inc. | |
SurgiQuest, Inc.
SurgiQuest, Inc. Medical SpecialtiesHealth Technology SurgiQuest, Inc. engages in developing, manufacturing, and marketing of access technologies for minimally invasive surgery. It offers laproscopic surgical access system, enabling a variety of complex laproscopic procedures. The company was founded by Kourosh Azarbarzin on April 17, 2006 and is headquartered in Utica, NY. | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
Reeve Foundation - Presidio Partners NRT LP
Reeve Foundation - Presidio Partners NRT LP Investment ManagersFinance Reeve Foundation - Presidio Partners NRT LP is a special purpose vehicle formed to invest in NeuroRecovery Technologies Inc. | Finance |
Corsair Pharma, Inc.
Corsair Pharma, Inc. BiotechnologyHealth Technology Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA. | Health Technology |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | Commercial Services |
Velocity Pharmaceutical Holdings LLC
Velocity Pharmaceutical Holdings LLC Financial ConglomeratesFinance Velocity Pharmaceutical Holdings LLC operates as a holding American company. | Finance |